TrialBlood advances2024

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.

Yaqi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.